BAY COLONY ADVISORY GROUP, INC D/B/A BAY COLONY ADVISORS Regeneron Pharmaceuticals, Inc. Transaction History

BAY COLONY ADVISORY GROUP, INC D/B/A BAY COLONY ADVISORS portfolio value:

$1.53M
portfolio value

BAY COLONY ADVISORY GROUP, INC D/B/A BAY COLONY ADVISORS quarter portfolio value change:

+16.53%
quarter

Regeneron Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -0.45% -10 shares 233K $688.87 2.22K
Q2 2022 share Decrease -16.50% -442 shares -570K $591.13 2.23K
Q1 2022 share Decrease -8.32% -243 shares 26K $698.42 2.67K
Q4 2021 share Increase +4.10% 115 shares 146K $642.51 2.92K
Q3 2021 share Increase +16.28% 393 shares 351K $605.18 2.80K
Q2 2021 share Decrease -0.12% -3 shares 204K $558.54 2.41K
Q1 2021 share Increase +53.46% 842 shares 383K $473.14 2.41K
Q4 2020 share Increase +39.88% 449 shares 131K $483.11 1.57K
Q3 2020 share Increase 0.00% 1.12K shares 630K $559.78 1.12K
Q1 2020 share Decrease -100.00% -693 shares -249K $488.29 0
Q4 2019 share Increase 0.00% 693 shares 249K $375.48 693